San Francisco, California, United States The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Clinical Trials, Health Care. Among the most popular portfolio startups of the fund, we may highlight Bacterial Barcodes, Tranzyme, Corus Pharma. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2005. The average startup value when the investment from Pacific Rim Ventures is 50-100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. This Pacific Rim Ventures works on 46 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2006.
The typical case for the fund is to invest in rounds with more than 10 participants. Despite the Pacific Rim Ventures, startups are often financed by JPMorgan Partners (JPMP), Burrill & Company, Zesiger Capital. The meaningful sponsors for the fund in investment in the same round are MDS Capital, Burrill & Company, WestRiver Group, LLC. In the next rounds fund is usually obtained by Thomas, McNerney & Partners, Quaker BioVentures, Houston Angel Network.
The overall number of key employees were 5.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Add Partners | England, London, United Kingdom |
| Almeda Ventures | Israel, Tel Aviv, Tel Aviv District |
| ANTS Capital | China, Guangdong, Guangzhou |
| Dig Ventures | England, London, United Kingdom |
| Donaldson, Lufkin & Jenrette | New York, New York, United States |
| Energy & Minerals Group | Houston, Texas, United States |
| Equity Resources Group | Cambridge, Massachusetts, United States |
| Gothams | California, San Francisco, United States |
| HaitaiChuangxin Ziben | - |
| Jacobs Capital Group | California, Pasadena, United States |
| Konka Group | China, Guangdong, Shenzhen |
| Miami Angels | Florida, Miami, United States |
| NIPR | Kansas City, Missouri, United States |
| Quest Software | Aliso Viejo, California, United States |
| REach | Chicago, Illinois, United States |
| Safar | - |
| Sinobioway Group | Beijing, China, Haidian |
| The Epic Groundwater Challenge | Gauteng, NA - South Africa, South Africa |
| U.S. Global Investors | San Antonio, Texas, United States |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tranzyme | 13 May 2005 | Durham, North Carolina, United States | |||
Idun Pharmaceuticals | $27M | 15 Jun 2004 | San Diego, California, United States | ||
Corus Pharma | $65M | 13 Apr 2004 | Seattle, Washington, United States | ||
Bacterial Barcodes | $6M | 12 Feb 2003 | Houston, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tranzyme | 13 May 2005 | Durham, North Carolina, United States | |||
Idun Pharmaceuticals | $27M | 15 Jun 2004 | San Diego, California, United States | ||
Corus Pharma | $65M | 13 Apr 2004 | Seattle, Washington, United States | ||
Bacterial Barcodes | $6M | 12 Feb 2003 | Houston, Texas, United States |
